Chemical inhibitors of LIN-7 can achieve functional inhibition through various mechanisms, primarily by preventing necessary phosphorylation events that are crucial for the protein's activity. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), leading to phosphorylation which can result in the functional inhibition of LIN-7 through altered trafficking or degradation. Conversely, Gö6983, Bisindolylmaleimide I, Staurosporine, Calphostin C, Chelerythrine, Ro-31-8220, GF 109203X, Hispidin, Ruboxistaurin, Enzastaurin, and Sotrastaurin operate on the principle of inhibiting PKC, which is essential for LIN-7's phosphorylation-driven functionality. For instance, Gö6983 prevents LIN-7 from undergoing phosphorylation, thereby inhibiting its ability to perform its biological role. Bisindolylmaleimide I similarly inhibits PKC, which would otherwise facilitate the phosphorylation and subsequent activity of LIN-7.
Additionally, Staurosporine, a broad-spectrum kinase inhibitor, can inhibit PKC among other kinases, leading to a reduction in LIN-7 activity by preventing its phosphorylation. Calphostin C and Chelerythrine also target PKC, with the former potentially decreasing LIN-7 activity through reduced phosphorylation. Ro-31-8220 further exemplifies this approach by inhibiting PKC, which is likely to block necessary phosphorylation events for LIN-7 function. GF 109203X, a potent PKC inhibitor, can hinder LIN-7's phosphorylation and therefore its function. Hispidin's inhibition of PKC similarly can lead to a decrease in LIN-7's functional activity. Ruboxistaurin and Enzastaurin selectively inhibit PKCβ, an isoform that may be directly involved in LIN-7's phosphorylation and activity. Finally, Sotrastaurin, with its ability to inhibit several PKC isoforms, can prevent phosphorylation-dependent processes that are essential for LIN-7's biological role. Through these varied but interconnected mechanisms, each chemical can contribute to the functional inhibition of LIN-7 by targeting the phosphorylation pathways that regulate its activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates LIN-7, potentially leading to its functional inhibition through altered trafficking or degradation. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Gö6983 is a PKC inhibitor, potentially preventing the phosphorylation of LIN-7, thereby inhibiting its function as it may rely on phosphorylation for activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I inhibits PKC, which could prevent LIN-7 phosphorylation and subsequent functional activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that can inhibit PKC, potentially leading to reduced phosphorylation and inhibition of LIN-7 function. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $336.00 $1642.00 | 20 | |
Calphostin C inhibits PKC, possibly leading to decreased phosphorylation and functional inhibition of LIN-7. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a PKC inhibitor that could prevent phosphorylation-dependent processes essential for LIN-7 function. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $90.00 $240.00 | 17 | |
Ro-31-8220 inhibits PKC, which may inhibit LIN-7 function by blocking necessary phosphorylation events. | ||||||
Hispidin | 555-55-5 | sc-203998 | 5 mg | $408.00 | ||
Hispidin is a PKC inhibitor that could inhibit the phosphorylation and thus the function of LIN-7. | ||||||
Ruboxistaurin | 169939-94-0 | sc-507364 | 25 mg | $1080.00 | ||
Ruboxistaurin selectively inhibits PKCβ, which may be involved in phosphorylation processes critical for LIN-7 function. | ||||||
Enzastaurin | 170364-57-5 | sc-364488 sc-364488A sc-364488B | 10 mg 50 mg 200 mg | $254.00 $600.00 $1687.00 | 3 | |
Enzastaurin is a PKCβ inhibitor which might inhibit LIN-7 activity by blocking its phosphorylation. | ||||||